The prognosis of clinical stage IIIa non‐small cell lung cancer in Taiwan
The prognosis of clinical stage IIIa non‐small cell lung cancer in Taiwan
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Lung cancer is the leading cause of cancer death. The treatment of stage IIIa remained the most controversial of all stages of non‐small cell lung cancer (NSCLC). We reported on the heterogenicity and current treatment strategies of stage IIIa NSCLC in Taiwan. This study is a retrospective analysis using data from the Taiwan Society of Cancer Regis...
Alternative Titles
Full title
The prognosis of clinical stage IIIa non‐small cell lung cancer in Taiwan
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_07809a662ca54deeaa585f547eb2cf96
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_07809a662ca54deeaa585f547eb2cf96
Other Identifiers
ISSN
2045-7634
E-ISSN
2045-7634
DOI
10.1002/cam4.6357
